NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats

Journal of Neurotrauma

Volumn 22, Issue 2, 2005, Pages 266-276

  Zhong, Chunlong ^a,b   Zhao, Xueren ^a   Sarva, Jayaprakash ^c   Kozikowski, Alan ^c   Neale, Joseph H ^d   Lyeth, Bruce G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Fluid percussion; Glutamate; Hippocampus; Metabotropic glutamate receptor; N acetylaspartylglutamate (NAAG); Traumatic brain injury

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; CELL MARKER; FLUORO JADE B; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II INHIBITOR; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR ANTAGONIST; N ACETYLASPARTYLGLUTAMIC ACID; UNCLASSIFIED DRUG; ZJ 43;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INJURY; BRAIN PROTECTION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME INHIBITION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; RAT; RECTUM TEMPERATURE;

EID: 14744296113     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2005.22.266     Document Type: Article

References (46)

1. ALLEN, J.W., IVANOVA, S.A., FAN, L., ESPEY, M.G., BASILE, A.S., and FADEN, A.I. (1999). Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury. J. Pharmacol. Exp. Ther. 290, 112-120.
2. BISCHOFBERGER, J., and SCHILD, D. (1996). Glutamate and N-acetylaspartylglutamate block HVA calcium currents in frog olfactory bulb interneurons via an mGluR2/3-like receptor. J. Neurophysiol. 76, 2089-2092.
3. BRUNO, V., WROBLEWSKA, B., WROBLEWSKI, J.T., FIORE, L., and NICOLETTI, F. (1998). Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells. Neuroscience 85, 751-757.
4. BULLOCK, R., LYETH, B.G., and MUIZELAAR, J.P. (1999). Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery 45, 207-217.
5. BZDEGA, T., CROWE, S.L., RAMADAN, E.R., et al. (2004). The cloning and characterization of a second brain enzyme with NAAG peptidase activity. J. Neurochem. 89, 627-635.
6. DANBOLT, N.C. (1994). The high affinity uptake system for excitatory amino acids in the brain. Prog. Neurobiol. 44, 377-396.
7. DIXON, C.E., LYETH, B.C., POVLISHOCK, J.T., et al. (1987). A fluid percussion model of experimental brain injury in the rat. J. Neurosurg. 67, 110-119.
8. FADEN, A.I., DEMEDIUK, P., PANTER, S.S., and VINK, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 798-800.
9. GARRIDO SANABRIA, E.R., WOZNIAK, K.M., SLUSHER, B.S., and KELLER, A. (2004). GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism. J. Neurophysiol. 91, 182-193.
10. GHADGE, G.D., SLUSHER, B.S., BODNER, A., et al. (2003). Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial arnyotrophic lateral sclerosis models. Proc. Natl. Acad. Sci. USA 100, 9554-9559.
11. GLOBUS, M.Y., ALONSO, O., DIETRICH, W.D., BUSTO, R., and GINSBERG, M.D. (1995). Glutamate release and free radical production following brain injury. J. Neurochem. 65, 1704-1711.
12. GUNDERSEN, H.J. (1986). Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J. Microsc. 143, 3-45.
13. HALLAM, T.M., FLOYD, C.L., FOLKERTS, M.M., et al. (2004). Comparison of behavioral deficits and acute neuronal degeneration in rat lateral fluid percussion and weight-drop brain injury models. J. Neurotrauma 21, 521-539.
14. HANSSON, E., BLOMSTRAND, F., KHATIBI, S., OLSSON, T., and RONNBACK, L. (1997). Glutamate induced astroglial swelling-methods and mechanisms. Acta Neurojchir. Suppl. (Wien) 70, 148-151.
15. JACKSON, P.P., COLE, D.C., SLUSHER, B.S., et al. (1996). Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase W-acetylated-a-linked acidic dipeptidase. J. Med. Chem. 39, 619-622.
16. KATAYAMA, Y., BECKER, O.P., TAMURA, T., and HOVDA, D.A. (1990). Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J. Neurosurg. 73, 889-900.
17. + medium causes inhibition of glutamate and aspartate uptake and increases their release. J. Cereb. Blood Flow Metab. 15, 409-416.
18. KINGSTON, A.E., ORNSTEIN, P.L., WRIGHT, R.A., et al. (1998). LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 37, 1-12.
19. KOZIKOWSKI, A.P., ZHANG, J., NAN, F., et al. (2004). Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents. J. Med. Chem. 47, 1729-1738.
20. LYETH, B.C., GONG, Q.Z., SHIELDS, S., MUIZELAAR, J.P., and BERMAN, R.F. (2001). Group I metabotropic glutamate antagonist reduces acute neuronal degeneration and behavioral deficits after traumatic brain injury in rats. Exp. Neurol. 169, 191-199.
21. MCINTOSH, T.K., VINK, R., NOBLE, L., et al. (1989). Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 28, 233-244.
22. NEALE, J.H., BZDEGA, T., and WROBLEWSKA, B. (2000). N- Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 75, 443-452.
23. NIH. (1999). Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilitation of Persons with Traumatic Brain Injury. JAMA 282, 974-983.
24. OLSZEWSKI, R., BUHKARI, N., ZHOU, J., et al. (2004). NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. J. Neurochem. 89, 876-885.
25. RIBA-BOSCH, A., and PEREZ-CLAUSELL, J. (2004). Response to kainic acid injections: changes in staining for zinc, FOS, cell death and glial response in the rat forebrain. Neuroscience 125, 803-818.
26. RONG, S.B., ZHANG, J., NEALE, J.H., WROBLEWSKI, J.T., WANG, S., and KOZIKOWSKI, A.P. (2002). Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors. J. Med. Chem. 45, 4140-4152.
27. SATO, M., CHANG, E., IGARASHI, T., and NOBLE, L.J. (2001). Neuronal injury and loss after traumatic brain injury: time course and regional variability. Brain Res. 917, 45-54.
28. SCHMUED, L.C., ALBERTSON, C., and SLIKKER, W.J. (1997). Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751, 37-46.
29. SCHMUED, L.C., and HOPKINS, K.J. (2000). Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874, 123-130.
30. SCHWEITZER, C, KRATZEISEN, C., ADAM, G., et al. (2000). Characterization of -LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors. Neuropharmacology 39, 1700-1706.
31. SLUSHER, B.S., VORNOV, J.J., THOMAS, A.G., et al. (1999). Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat. Med. 5, 1396-1402.
32. STERIO, D.C. (1984). The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc. 134, 127-136.
33. TAKAHASHI, M., BILLUPS, B., ROSSI, D., SARANTIS, M., HAMANN, M., and ATTWELL, D. (1997). The role of glutamate transporters in glutamate homeostasis in the brain. J. Exp. Biol. 200, 401-409.
34. WEST, M.J., SLOMIANKA, L., and GUNDERSEN, H.J. (1991). Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231, 482-497.
35. WROBLEWSKA, B., WROBLEWSKI, J.T., SAAB, O.K., and NEALE, J.H. (1993). N-Acetylaspartylglutamate inhibits forskolin-stimulated cyclic AMP levels via a metabotropic glutamate receptor in cultured cerebellar granule cells. J. Neurochem. 61, 943-948.
36. WROBLEWSKA, B., WROBLEWSKI, J.T., PSHENICHKIN, S., SURIN, A., SULLIVAN, S.E., and NEALE, J.H. (1997). N-Acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem. 69, 174-181.
37. WROBLEWSKA, B., SANTI, M.R., and NEALE, J.H. (1998). N- Acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes. Glia 24, 172-179.
38. XI, Z.X., BAKER, D.A., SHEN, H., CARSON, D.S., and KALIVAS, P.W. (2002). Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens. JPET 300, 162-171.
39. YAMAMOTO, T., NOZAKI-TAGUCHI, N., SAKASHITA, Y., and INAGAKI, T. (2001 a). Inhibition of spinal N-acetylated-alpha-linked acidic dipeptidase produces an antinociceptive effect in the rat formalin test. Neuroscience 102, 473-479.
40. YAMAMOTO, T., NOZAKI-TAGUCHI, N., and YOSHIHIKO, S. (2001b). Spinal N-acetyl-[alpha]-linked acidic dipeptidase (NAALADase) inhibition attenuates mechanical allodynia induced by paw carrageenan injection in the rat. Brain Res. 909, 138-144.
41. YAMAMOTO, T., HIRASAWA, S., WROBLEWSKA, B., et al. (2004). Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Eur. J. Neurosci. 20, 483-494.
42. ZHANG, W., SLUSHER, B., MURAKAWA, Y., et al. (2002). GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats. J. Neurol. Sci. 194, 21-28.
43. 3H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance.. Eur. J. Neurosci. 13, 340-346.
44. ZHAO, X., AHRAM, A., MUIZELAAR, J.P., BERMAN, R.F., and LYETH, E.G. (2003). Early loss of astrocytes after experimental traumatic brain injury. Glia 44, 140-152.
45. ZUCCHINI, S., BUZZI, A., BERGAMASCHI, M., PIETRA, C., VILLETTI, G., and SIMONATO, M. (2002). Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist. Neuroreport 13, 2071-2074.
46. ZWIENENBERG, M., GONG, Q.Z., BERMAN, R.F., MUIZELAAR, J.P., and LYETH, B.C. (2001). The effect of group II and III metabotropic glutamate receptor activation on neuronal injury in a rodent model of traumatic brain injury. Neurosurgery 48, 1119-1126.